Committed to Your Prostate Health Education
Garrett D. Pohlman, MD
Prostate Health Education in a Podcast!
So the big question is this: how can men and those who care for them better educate themselves regarding prostate health, the conditions that affect the prostate, and the latest technology in managing these conditions? That is the question and this podcast will provide the answers. My name is Garrett D. Pohlman, MD, founder and host of The Prostate Health Podcast. On a weekly basis I will be chatting with experts, innovators, and leaders in the field of Urology – sharing useful information with the general public to improve their lives and increase their overall health.
Get Dr. Pohlman’s FREE Guide – What to Expect From
Your First Urology Appointment
71: Extending Survival with a New Treatment for Men with Advanced Prostate Cancer – A. Oliver Sartor, MD
We are happy to have an international expert in the arena of the treatment of advanced prostate cancer joining us today. We are excited to talk to him about a new treatment that is extending the survival of men with advanced prostate cancer.
Dr. Oliver Sartor is an internationally recognized expert in prostate cancer. He is currently the Assistant Dean for Oncology at Tulane University’s School of Medicine, Medical Director of the Tulane Cancer Center, and the Ward Professor for Cancer Research. His medical practice and research have focused on prostate cancer since 1990 when he finished a fellowship at the National Cancer Institute.
70: Bladder Cancer Episode: Bladder-Preserving Trimodality Therapy as an Alternative To Radical Cystectomy – Abhishek Solanki, MD, MS
Although the primary focus of this podcast is prostate health, we will occasionally break from that topic to cover other important subjects related to urology. Today, we have a special bonus episode about bladder cancer.
We are happy to have Dr. Abhi Solanki joining us on the podcast today! Dr. Solanki is a Radiation Oncologist. After completing his residency training in Radiation Oncology at the University of Chicago Pritzker School of Medicine, he joined the faculty at Loyola University Medical Center, where he is currently an Associate Professor in the Department of Radiation Oncology. He also serves as Quality Medical Director in the department and the Chair of the Genitourinary Cancer Disease Committee at the Cancer Center at Loyola. Much of his clinical focus includes treating genitourinary cancers, including prostate, bladder, kidney, and testicular cancer.
In this episode, we review some of the basics of bladder cancer. We then get you up to speed with all you need to know about bladder-preserving Trimodality Therapy as an alternative to radical bladder removal for muscle-invasive bladder cancer. Stay tuned for more!
69: PARP-Inhibitors: Entering a New Era of Personalized Treatment for Advanced Prostate Cancer – Emmanuel Antonarakis, MD
There is a continuous explosion of new and innovative therapies for men with advanced prostate cancer. Recently, two different PARP-Inhibitors were approved by the FDA for use. Those drugs were the first in their class to have been approved as personalized therapy for certain individuals with advanced prostate cancer.
Today, we have Dr. Emmanuel Antonarakis, a world-class expert in the area of targeted therapy for prostate cancer, joining us to talk about the two new medications and explain who might be eligible for that kind of therapy. Be sure to stay tuned for more!
The Grand Rounds in Urology™ (GRU) Community is a premier network for urologists, medical oncologists, radiation oncologists, and other healthcare providers to keep up-to-date with best practices and current clinical updates for the treatment of urologic diseases and conditions, especially genitourinary cancers. GRU provides dissemination of knowledge through online content, live meetings, lectures, conversations, information sharing, and constructive debates, ultimately improving physician performance and patient outcomes throughout the world.
Prostate Conditions Education Council (PCEC) is a national non-profit dedicated to spreading awareness about prostate health through early detection and research. As the leading innovative organization, saving and improving the lives of men and their loved ones, PCEC sets the pace in early detection, research, education and awareness for prostate cancer and all prostate conditions.
As the prostate cancer landscape has evolved, so have we. Today, we are the destination for taking action to end prostate cancer and making prostate cancer research a national priority. With a new name, ZERO – The End of Prostate Cancer, we are still on the front lines in Washington, DC and grassroots communities to provide much-needed programs that positively impact the lives of both men at risk and men suffering from this disease. We’re providing men and families with educational resources and funding promising research for improved early detection options. Our mantra to support, educate, and activate is mobilizing a like-minded, passionate, and multigenerational army of advocates across the country to end prostate cancer.
Whether you are a 40-year-old father of three young children in the prime of your life or a 65-year-old excited to enjoy your retirement and spend time with your grandchildren, the face of prostate cancer can look very different. What unites us all is our steadfast commitment to eliminate the pain and suffering and create Generation ZERO – the first generation of men free from prostate cancer.
I may earn a commission from the sponsors listed on this website. By clicking a link, I may earn a small commission. You can read the full disclosure here.
Better Prostate Education is our Mission!
Subscribe to the show on any of these podcast apps